A detailed history of Operose Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Operose Advisors LLC holds 1,401 shares of MRK stock, worth $140,184. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,401
Previous 1,551 9.67%
Holding current value
$140,184
Previous $192,000 17.19%
% of portfolio
0.05%
Previous 0.07%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $16,672 - $19,345
-150 Reduced 9.67%
1,401 $159,000
Q2 2024

Aug 08, 2024

SELL
$123.8 - $132.96 $9,285 - $9,972
-75 Reduced 4.61%
1,551 $192,000
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $89,799 - $104,636
793 Added 95.2%
1,626 $214,000
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $157,282 - $171,161
-1,570 Reduced 65.33%
833 $90,000
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $208,576 - $231,632
2,026 Added 537.4%
2,403 $247,000
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $87 - $112
1 Added 0.27%
377 $41,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $21,132 - $23,740
250 Added 198.41%
376 $32,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $9,107 - $11,408
126 New
126 $10,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.